Jan 02, 2018 13:01 pm UTC| Business
-- C-Scape was well tolerated across all doses studied in Phase 1 trial, with no drug-drug interaction between the previously approved compounds when dosed in combination -- -- C-Scape is a combination of ceftibuten and...
Optinose Announces $100 Million Debt Financing from Athyrium Capital Management
Jan 02, 2018 13:01 pm UTC| Business
YARDLEY, Pa., Jan. 02, 2018 -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it has entered into a $100 million...
Jan 02, 2018 13:01 pm UTC| Business
-- Investigational drug has potential to treat certain MDR gram-negative pathogens, including carbapenem-resistant Enterobacteriaceae (CRE) -- -- FDA sets action date of June 25, 2018 -- SOUTH SAN FRANCISCO, Calif.,...
UroGen Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference
Jan 02, 2018 13:01 pm UTC| Business
RA’ANANA, Israel and NEW YORK, Jan. 02, 2018 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on...
Grabbr Selects FischTank Marketing and PR as Agency of Record
Jan 02, 2018 13:01 pm UTC| Business
FRANKLIN, Tenn., Jan. 02, 2018 -- Grabbr, a social referral marketing platform that leverages and promotes organic social shares as a currency in exchange for products, services or discounts, today announced it has...
Jan 02, 2018 13:01 pm UTC| Business
Saint Petersburg, FL, Jan. 02, 2018 -- Nuvus Blockchain (https://www.nuvus.io), a Nuvus Corp company, formed to build the New Global Exchange Platform with big data and supply chain verification ecosystem using...
Jan 02, 2018 13:01 pm UTC| Business
PHOENIX, Jan. 02, 2018 -- Mobivity Holdings Corp. (OTCQB:MFON), makers of the award-winning platform for intelligent and personalized marketing in the real world, and Chanticleer Holdings Inc. (NASDAQ:BURG), the owners...